Your browser doesn't support javascript.
loading
Antiretroviral Therapy in Relation to Birth Outcomes among HIV-infected Women: A Cohort Study.
Li, Nan; Sando, Mary Mwanyika; Spiegelman, Donna; Hertzmark, Ellen; Liu, Enju; Sando, David; Machumi, Lameck; Chalamilla, Guerino; Fawzi, Wafaie.
Affiliation
  • Li N; Department of Global Health and Population, Harvard T.H. Chan School of Public Health (HSPH), Boston, Massachusetts.
  • Sando MM; Management and Development for Health, Dar es Salaam, Tanzania.
  • Spiegelman D; Departments of Epidemiology, HSPH, Boston, Massachusetts Biostatistics, HSPH, Boston, Massachusetts.
  • Hertzmark E; Biostatistics, HSPH, Boston, Massachusetts.
  • Liu E; Department of Global Health and Population, Harvard T.H. Chan School of Public Health (HSPH), Boston, Massachusetts.
  • Sando D; Management and Development for Health, Dar es Salaam, Tanzania.
  • Machumi L; Management and Development for Health, Dar es Salaam, Tanzania.
  • Chalamilla G; Management and Development for Health, Dar es Salaam, Tanzania.
  • Fawzi W; Department of Global Health and Population, Harvard T.H. Chan School of Public Health (HSPH), Boston, Massachusetts Departments of Epidemiology, HSPH, Boston, Massachusetts Nutrition, HSPH, Boston, Massachusetts.
J Infect Dis ; 213(7): 1057-64, 2016 Apr 01.
Article in En | MEDLINE | ID: mdl-26265780
ABSTRACT
Although the beneficial effects of antiretroviral (ARV) therapy for preventing mother-to-child transmission are indisputable, studies in developed and developing countries have reported conflicting findings on the association between ARV exposure and adverse birth outcomes. We conducted a prospective observational study at 10 human immunodeficiency virus (HIV) care and treatment centers in Dar es Salaam, Tanzania. Multivariate log-binomial regression was used to investigate the associations between ARV use and adverse birth outcomes among HIV-negative HIV-exposed infants. Our findings demonstrate an increased risk of adverse birth outcomes associated with the use of highly active antiretroviral therapy during pregnancy. Further studies are needed to investigate the underlying mechanisms and identify the safest ARV regimens for use during pregnancy.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pregnancy Complications, Infectious / Infant, Low Birth Weight / HIV Infections / Anti-HIV Agents / Antiretroviral Therapy, Highly Active / Premature Birth Type of study: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Newborn / Pregnancy Country/Region as subject: Africa Language: En Journal: J Infect Dis Year: 2016 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pregnancy Complications, Infectious / Infant, Low Birth Weight / HIV Infections / Anti-HIV Agents / Antiretroviral Therapy, Highly Active / Premature Birth Type of study: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Newborn / Pregnancy Country/Region as subject: Africa Language: En Journal: J Infect Dis Year: 2016 Document type: Article